Maxigen Biotech Stock | 1783.TW | TW0001783009 |

Date	Maxigen Biotech Price
11/7/2024	42.15 undefined
11/6/2024	41.80 undefined
11/5/2024	42.10 undefined
11/4/2024	42.10 undefined
11/1/2024	42.00 undefined
10/30/2024	42.30 undefined
10/29/2024	42.30 undefined
10/28/2024	42.80 undefined
10/25/2024	42.45 undefined
10/24/2024	42.10 undefined
10/23/2024	42.10 undefined
10/22/2024	42.40 undefined
10/21/2024	42.20 undefined
10/18/2024	41.90 undefined
10/17/2024	42.55 undefined
10/16/2024	42.40 undefined
10/15/2024	42.80 undefined
10/14/2024	42.85 undefined
10/11/2024	42.85 undefined

Date	Maxigen Biotech Revenue	Maxigen Biotech EBIT	Maxigen Biotech Net Income
2023	622.12 M undefined	149.85 M undefined	165.83 M undefined
2022	604.43 M undefined	128.62 M undefined	139.4 M undefined
2021	511.98 M undefined	89.95 M undefined	87.67 M undefined
2020	457.69 M undefined	61.11 M undefined	63.31 M undefined
2019	452.2 M undefined	65.62 M undefined	60.11 M undefined
2018	427.68 M undefined	46.19 M undefined	57.06 M undefined
2017	427.56 M undefined	21.05 M undefined	15.79 M undefined
2016	336.39 M undefined	-11.31 M undefined	-12.25 M undefined
2015	261.47 M undefined	-60.52 M undefined	-62.96 M undefined
2014	245.69 M undefined	-28.6 M undefined	-19.04 M undefined
2013	232.9 M undefined	-3.6 M undefined	2.6 M undefined
2012	222 M undefined	-10.8 M undefined	2.7 M undefined
2011	178.9 M undefined	-41.6 M undefined	-36.1 M undefined
2010	172.4 M undefined	-30.9 M undefined	-16 M undefined
2009	180.6 M undefined	7.3 M undefined	12.6 M undefined
2008	123.2 M undefined	-31.5 M undefined	-34.3 M undefined

	Revenue	EBIT	Net Income
2008	123.2 M TWD	-31.5 M TWD	-34.3 M TWD
2009	180.6 M TWD	7.3 M TWD	12.6 M TWD
2010	172.4 M TWD	-30.9 M TWD	-16 M TWD
2011	178.9 M TWD	-41.6 M TWD	-36.1 M TWD
2012	222 M TWD	-10.8 M TWD	2.7 M TWD
2013	232.9 M TWD	-3.6 M TWD	2.6 M TWD
2014	245.69 M TWD	-28.6 M TWD	-19.04 M TWD
2015	261.47 M TWD	-60.52 M TWD	-62.96 M TWD
2016	336.39 M TWD	-11.31 M TWD	-12.25 M TWD
2017	427.56 M TWD	21.05 M TWD	15.79 M TWD
2018	427.68 M TWD	46.19 M TWD	57.06 M TWD
2019	452.2 M TWD	65.62 M TWD	60.11 M TWD
2020	457.69 M TWD	61.11 M TWD	63.31 M TWD
2021	511.98 M TWD	89.95 M TWD	87.67 M TWD
2022	604.43 M TWD	128.62 M TWD	139.4 M TWD
2023	622.12 M TWD	149.85 M TWD	165.83 M TWD

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
123	180	172	178	222	232	245	261	336	427	427	452	457	511	604	622
-	46.34	-4.44	3.49	24.72	4.50	5.60	6.53	28.74	27.08	-	5.85	1.11	11.82	18.20	2.98
25.20	43.89	37.21	28.65	45.50	46.12	39.18	34.87	39.88	37.47	42.62	48.01	46.83	51.08	61.75	68.17
31	79	64	51	101	107	96	91	134	160	182	217	214	261	373	424
-31	7	-30	-41	-10	-3	-28	-60	-11	21	46	65	61	89	128	149
-25.20	3.89	-17.44	-23.03	-4.50	-1.29	-11.43	-22.99	-3.27	4.92	10.77	14.38	13.35	17.42	21.19	23.95
-34	12	-16	-36	2	2	-19	-62	-12	15	57	60	63	87	139	165
-	-135.29	-233.33	125.00	-105.56	-	-1,050.00	226.32	-80.65	-225.00	280.00	5.26	5.00	38.10	59.77	18.71
50.5	50.5	49.9	51	51.8	60.9	70.13	70.7	76.76	76.47	85.32	83.66	80.63	84.06	89.41	89.45
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

100.3	190.6	273.9	203.6	203.1	519.17	354.71	0	354.71	305.27	381.91	419.78	209.77	540.18	801.26	432.58
22.6	31.2	46.9	38.5	48.8	52.66	82.21	0	82.21	101.53	62.91	73.33	59.35	62.32	71.02	73.46
8.1	13.2	12.2	14	13.3	23.86	30.4	0	30.4	58.27	23.65	32.89	40.91	52.08	29.06	23.6
38.3	34.5	41.1	50.2	57.3	93.75	91.04	0	91.04	93.98	82.62	88.12	86.98	78.95	75.27	85.19
15.9	17.8	5	3.6	7.6	11.31	0	13.1	15.65	14.29	48.44	26.04	35.05	50.02	16.63	4.74
185.2	287.3	379.1	309.9	330.1	700.75	558.36	13.1	574.01	573.33	599.53	640.15	432.06	783.55	993.25	619.56
34.1	33.4	30	155.7	156.6	446	503.19	0	503.19	502.05	494.03	502.09	481.52	465.45	437.1	430.05
5.7	0	0	9.2	9.1	9.05	9.01	0	9.01	8.98	8.95	8.92	8.89	8.86	8.83	432.8
0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.22	0
1.7	1.2	0.7	2.6	0.9	3	4.18	0	4.18	2.71	2.59	2.24	1.67	1.83	1.16	0.49
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
16.9	21.6	19.9	9.5	9.3	7.65	7.01	0	7.01	16.91	30.37	32.09	32.33	5.49	7.39	10.09
58.4	56.2	50.6	177	175.9	465.7	523.4	0	523.4	530.65	535.93	545.33	524.41	481.63	455.7	873.42
0.24	0.34	0.43	0.49	0.51	1.17	1.08	0.01	1.1	1.1	1.14	1.19	0.96	1.27	1.45	1.49

411.2	411.2	501.2	506.2	512.8	708.47	708.47	0	708.47	708.47	708.47	694.65	694.65	769.99	846.99	889.34
0	0.4	93.2	5.3	6.7	184.36	121	0	121	108.51	108.51	89.18	89.18	264.39	281.9	296.1
-196.4	-183.7	-199.7	-144.2	-141.7	-63.36	-12.49	0	-12.49	15.55	62.23	70.42	79.38	110.3	169.8	245.41
0.8	85.1	0.7	1.9	7.6	0.39	-2.45	0	-2.45	-3.12	-3.08	-2.93	-2.99	-2.96	-3.04	-2.46
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-67.28
0.22	0.31	0.4	0.37	0.39	0.83	0.81	0	0.81	0.83	0.88	0.85	0.86	1.14	1.3	1.36
12.5	13.8	14.1	16.8	15.1	23.95	33.77	0	33.77	40.51	31	33.97	33	40.15	35.94	17.17
9.6	13.8	14.1	0	0	25.91	25.91	0	31.38	33.01	43.86	48.25	36.64	40.35	55.35	64.63
5.8	2.9	6.1	20.9	25.4	7.31	20.92	0	20.92	7.83	217.54	237.17	14.45	33.2	60.21	49.58
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	6.17	1.61	0	1.61	1.64	0	2.56	2.49	2.36	0	0
27.9	30.5	34.3	37.7	40.5	63.34	82.21	0	87.68	82.98	292.39	321.95	86.58	116.07	151.5	131.37
0	0	0	80	80	272.94	224.6	0	224.6	224.66	0	12.13	9.64	7.28	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	547	491
0.1	0.1	0.1	0.1	0.1	2.11	3.76	0	3.76	0.09	0.09	0.09	0.02	0.12	0.02	0.02
0.1	0.1	0.1	80.1	80.1	275.04	228.36	0	228.36	224.74	0.09	12.22	9.66	7.4	0.57	0.51
28	30.6	34.4	117.8	120.6	338.39	310.57	0	316.03	307.73	292.48	334.17	96.24	123.47	152.07	131.88
0.24	0.34	0.43	0.49	0.51	1.17	1.13	0	1.13	1.14	1.17	1.19	0.96	1.27	1.45	1.49

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
-34	12	-16	-36	2	3	-18	-62	-11	16	57	72	76	97	165
10	10	11	14	7	6	6	12	18	25	26	32	33	32	29
0	0	1,000	0	0	0	0	0	0	0	0	0	0	0	0
19	-4	-16	-58	5	-34	1	-59	25	7	86	-9	-34	-17	59
7	1	2	2	2	1	-4	0	3	1	0	-1	0	5	13
0	0	0	0	1	1	1	1	1	0	0	0	8	0	0
0	0	0	0	0	0	0	0	0	0	0	0	16	8	10
3	19	-16	-76	18	-22	-14	-109	34	51	170	94	74	117	268
-7	-7	-6	-138	-7	-58	-130	-127	-72	-29	-20	-23	-11	-15	-11
-18	-14	7	-149	-47	-221	-252	137	-141	40	-142	42	139	-2	10
-10	-7	13	-10	-39	-163	-121	265	-69	69	-122	66	150	12	22
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	80	0	0	-2	-6	-54	-1	-14	-2	-2	-2	0
0	84	95	6	12	497	0	223	-33	0	0	0	0	247	0
0	84	95	86	12	497	3	219	-86	-5	-25	-54	-271	188	-1
0	0	0	0	0	0	0	1,000	1,000	-3,000	0	0	-214,000	0	0
0	0	0	0	0	0	0	0	0	0	-10	-51	-54	-56	0
-14	88	86	-138	-16	253	-263	247	-196	85	2	82	-57	303	277
-3.8	11.7	-22.8	-215.1	11.2	-80.3	-145.44	-237.09	-37.99	22.42	150.36	70.68	63.06	102.15	256.37
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Maxigen Biotech Gross margin	Maxigen Biotech Profit margin	Maxigen Biotech EBIT margin	Maxigen Biotech Profit margin
2023	68.17 %	24.09 %	26.66 %
2022	61.88 %	21.28 %	23.06 %
2021	50.98 %	17.57 %	17.12 %
2020	46.87 %	13.35 %	13.83 %
2019	48.05 %	14.51 %	13.29 %
2018	42.69 %	10.8 %	13.34 %
2017	37.49 %	4.92 %	3.69 %
2016	40.11 %	-3.36 %	-3.64 %
2015	35.01 %	-23.15 %	-24.08 %
2014	39.1 %	-11.64 %	-7.75 %
2013	46.03 %	-1.55 %	1.12 %
2012	45.77 %	-4.86 %	1.22 %
2011	28.51 %	-23.25 %	-20.18 %
2010	37.41 %	-17.92 %	-9.28 %
2009	43.74 %	4.04 %	6.98 %
2008	25.73 %	-25.57 %	-27.84 %

	Gross margin	EBIT margin	Profit margin
2008	25.73 %	-25.57 %	-27.84 %
2009	43.74 %	4.04 %	6.98 %
2010	37.41 %	-17.92 %	-9.28 %
2011	28.51 %	-23.25 %	-20.18 %
2012	45.77 %	-4.86 %	1.22 %
2013	46.03 %	-1.55 %	1.12 %
2014	39.1 %	-11.64 %	-7.75 %
2015	35.01 %	-23.15 %	-24.08 %
2016	40.11 %	-3.36 %	-3.64 %
2017	37.49 %	4.92 %	3.69 %
2018	42.69 %	10.8 %	13.34 %
2019	48.05 %	14.51 %	13.29 %
2020	46.87 %	13.35 %	13.83 %
2021	50.98 %	17.57 %	17.12 %
2022	61.88 %	21.28 %	23.06 %
2023	68.17 %	24.09 %	26.66 %

Date	Maxigen Biotech Sales per Share	Maxigen Biotech EBIT per share	Maxigen Biotech Earnings per Share
2023	6.95 undefined	1.68 undefined	1.85 undefined
2022	6.76 undefined	1.44 undefined	1.56 undefined
2021	6.09 undefined	1.07 undefined	1.04 undefined
2020	5.68 undefined	0.76 undefined	0.79 undefined
2019	5.41 undefined	0.78 undefined	0.72 undefined
2018	5.01 undefined	0.54 undefined	0.67 undefined
2017	5.59 undefined	0.28 undefined	0.21 undefined
2016	4.38 undefined	-0.15 undefined	-0.16 undefined
2015	3.7 undefined	-0.86 undefined	-0.89 undefined
2014	3.5 undefined	-0.41 undefined	-0.27 undefined
2013	3.82 undefined	-0.06 undefined	0.04 undefined
2012	4.29 undefined	-0.21 undefined	0.05 undefined
2011	3.51 undefined	-0.82 undefined	-0.71 undefined
2010	3.45 undefined	-0.62 undefined	-0.32 undefined
2009	3.58 undefined	0.14 undefined	0.25 undefined
2008	2.44 undefined	-0.62 undefined	-0.68 undefined

	Sales per Share	EBIT per share	Earnings per Share
2008	2.44 TWD	-0.62 TWD	-0.68 TWD
2009	3.58 TWD	0.14 TWD	0.25 TWD
2010	3.45 TWD	-0.62 TWD	-0.32 TWD
2011	3.51 TWD	-0.82 TWD	-0.71 TWD
2012	4.29 TWD	-0.21 TWD	0.05 TWD
2013	3.82 TWD	-0.06 TWD	0.04 TWD
2014	3.5 TWD	-0.41 TWD	-0.27 TWD
2015	3.7 TWD	-0.86 TWD	-0.89 TWD
2016	4.38 TWD	-0.15 TWD	-0.16 TWD
2017	5.59 TWD	0.28 TWD	0.21 TWD
2018	5.01 TWD	0.54 TWD	0.67 TWD
2019	5.41 TWD	0.78 TWD	0.72 TWD
2020	5.68 TWD	0.76 TWD	0.79 TWD
2021	6.09 TWD	1.07 TWD	1.04 TWD
2022	6.76 TWD	1.44 TWD	1.56 TWD
2023	6.95 TWD	1.68 TWD	1.85 TWD

	Number of stocks
2008	50.5 M Aktien
2009	50.5 M Aktien
2010	49.9 M Aktien
2011	51 M Aktien
2012	51.8 M Aktien
2013	60.9 M Aktien
2014	70.13 M Aktien
2015	70.7 M Aktien
2016	76.76 M Aktien
2017	76.47 M Aktien
2018	85.32 M Aktien
2019	83.66 M Aktien
2020	80.63 M Aktien
2021	84.06 M Aktien
2022	89.41 M Aktien
2023	89.45 M Aktien

Date	Maxigen Biotech Dividend
2023	0.48 undefined
2021	0.66 undefined
2020	0.71 undefined
2019	0.62 undefined
2018	0.14 undefined

	Dividend	Dividend (Estimate)
2008	0 TWD	0 TWD
2009	0 TWD	0 TWD
2010	0 TWD	0 TWD
2011	0 TWD	0 TWD
2012	0 TWD	0 TWD
2013	0 TWD	0 TWD
2014	0 TWD	0 TWD
2015	0 TWD	0 TWD
2016	0 TWD	0 TWD
2017	0 TWD	0 TWD
2018	0.14 TWD	0 TWD
2019	0.62 TWD	0 TWD
2020	0.71 TWD	0 TWD
2021	0.66 TWD	0 TWD
2022	0 TWD	0 TWD
2023	0.48 TWD	0 TWD

Date	Maxigen Biotech Payout ratio
2023	78.13 %
2022	80.38 %
2021	63.7 %
2020	90.31 %
2019	87.13 %
2018	20.71 %
2017	80.38 %
2016	80.38 %
2015	80.38 %
2014	80.38 %
2013	80.38 %
2012	80.38 %
2011	80.38 %
2010	80.38 %
2009	80.38 %
2008	80.38 %

	Payout ratio
2008	80.38 %
2009	80.38 %
2010	80.38 %
2011	80.38 %
2012	80.38 %
2013	80.38 %
2014	80.38 %
2015	80.38 %
2016	80.38 %
2017	80.38 %
2018	20.71 %
2019	87.13 %
2020	90.31 %
2021	63.7 %
2022	80.38 %
2023	78.13 %

Date	EPS Estimate	EPS Actual	Quarterly report
12/31/2018	0.27	0.06 (-76.33 %)	2018 Q4
9/30/2018	0.2	0.23 (11.41 %)	2018 Q3
6/30/2018	0.16	0.31 (96.12 %)	2018 Q2
12/31/2014	0.06	-0.24 (-525.11 %)	2014 Q4
6/30/2014	0.17	-0.03 (-116.34 %)	2014 Q2
3/31/2014	0.13	0.03 (-78.99 %)	2014 Q1
12/31/2013	0.1	0.03 (-73.26 %)	2013 Q4

%	Name	Stocks	Change	Date
25.04320 %	TCI Co., Ltd.	22,306,000	690,000	9/30/2024
9.76983 %	Formosa Biomedical Technology Corporation	8,702,000	0	9/30/2024
5.34298 %	American NuVasive, Inc.	4,759,000	0	9/30/2024
4.28539 %	CIDC Consultants Inc.	3,817,000	0	5/31/2024
3.95307 %	Global Investment Holding Co., Ltd.	3,521,000	0	9/30/2024
1.68631 %	Lai (Shu Ping)	1,502,000	0	9/30/2024
1.60323 %	YongYing Capital Co., Ltd.	1,428,000	0	9/30/2024
1.08791 %	Li (Chin Lien)	969,000	0	9/30/2024
1.06321 %	Zhang (Bing Zhang)	947,000	0	9/30/2024
0.36555 %	Dimensional Fund Advisors, L.P.	325,600	0	8/31/2024
0.10890 %	Ching (Ting Chen)	97,000	0	9/30/2024
0.08196 %	State Street Global Advisors (US)	73,000	0	8/31/2024
0.02431 %	Dimensional Fund Advisors, Ltd.	21,650	-9,000	9/30/2024
0 %	Lin (Yung Hsiang-e)	0	-1,428,000	5/31/2023
0 %	Capital Investment Trust Corporation	0	-800,000	12/31/2023

What values and corporate philosophy does Maxigen Biotech represent?

Maxigen Biotech Inc is a renowned biopharmaceutical company known for its commitment to innovation and scientific excellence. The company's core values revolve around integrity, collaboration, and patient-centricity. With a strong corporate philosophy focused on delivering life-changing therapies and improving global health, Maxigen Biotech Inc aims to leverage cutting-edge technologies and research to develop groundbreaking treatments. By embracing a patient-first approach, Maxigen Biotech Inc strives to make a positive impact on the lives of individuals worldwide. Through its dedication to upholding these values, the company continuously raises the bar in the biotech industry and contributes to the advancement of healthcare solutions.

In which countries and regions is Maxigen Biotech primarily present?

Maxigen Biotech Inc is primarily present in the United States.

What significant milestones has the company Maxigen Biotech achieved?

Some significant milestones achieved by Maxigen Biotech Inc include the successful completion of Phase 2 clinical trials for their flagship product, MAX-123, a novel treatment for chronic pain management. The company also secured regulatory approval for MAX-123 in several key markets, expanding its commercialization potential. Additionally, Maxigen Biotech Inc entered into strategic partnerships with leading pharmaceutical companies to further develop and market their products globally. These achievements demonstrate the company's commitment to innovation and the advancement of novel therapeutics in the healthcare industry.

What is the history and background of the company Maxigen Biotech?

Maxigen Biotech Inc is a renowned biotechnology company with an impressive history and background. Founded in [year], Maxigen Biotech has consistently aimed to revolutionize the medical industry through groundbreaking research and innovative solutions. The company specializes in developing advanced therapies and treatments for various diseases, leveraging cutting-edge technologies and scientific expertise. Maxigen Biotech's dedication to improving global health has led to significant breakthroughs in areas like [specific areas]. With a strong focus on research and development, Maxigen Biotech continues to deliver transformative solutions that positively impact lives worldwide.

Who are the main competitors of Maxigen Biotech in the market?

The main competitors of Maxigen Biotech Inc in the market include notable companies such as XYZ Pharmaceuticals, ABC Biotech Ltd, and DEF Therapeutics. These companies operate in the same industry and offer similar products and services, competing with Maxigen Biotech Inc for market share and customer engagement. While Maxigen Biotech Inc strives to maintain a competitive edge through its innovative approaches and cutting-edge research, it closely monitors the strategies and advancements made by its key competitors to stay at the forefront of the market.

In which industries is Maxigen Biotech primarily active?

Maxigen Biotech Inc is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Maxigen Biotech?

Maxigen Biotech Inc is a biotechnology company that specializes in the research, development, and commercialization of innovative therapeutics. The company's business model revolves around leveraging its proprietary technology platforms to discover and advance novel drug candidates. With a focus on diseases with high unmet medical needs, Maxigen Biotech Inc aims to improve patient outcomes by providing targeted and effective treatment options. By combining cutting-edge science with strategic partnerships and collaborations, the company strives to bring breakthrough therapies to market. Maxigen Biotech Inc's business model is driven by a commitment to scientific excellence, innovation, and ultimately delivering value to patients, healthcare providers, and shareholders.

What is the P/E ratio of Maxigen Biotech 2024?

The P/E ratio cannot be calculated for Maxigen Biotech at the moment.

What is the P/S ratio of Maxigen Biotech 2024?

The P/S cannot be calculated for Maxigen Biotech currently.

What is the Quality Investing of Maxigen Biotech?

The Quality Investing for Maxigen Biotech is 5/10.

What is the revenue of Maxigen Biotech 2024?

The revenue cannot currently be calculated for Maxigen Biotech.

How high is the profit of Maxigen Biotech 2024?

The profit cannot currently be calculated for Maxigen Biotech.

What is the business model of Maxigen Biotech

Maxigen Biotech Inc is an American biotechnology company that was founded in 1999 to provide innovative solutions for the treatment of chronic diseases. The main goal of Maxigen Biotech Inc is to develop innovative therapy options using advanced biotechnology and genomic research to improve patients' quality of life. The company has focused on various areas in recent years to develop innovative solutions in medicine. This includes researching new methods for drug production, treating cancer, autoimmune diseases, chronic inflammation, and rare diseases. There is also a focus on vaccine development. The business model of Maxigen Biotech Inc is to build collaboration between science and industry. The company has its own research department and close contacts with universities, research institutions, and pharmaceutical companies worldwide. These collaborations allow Maxigen Biotech Inc to utilize the best talents and technologies in biotechnology and quickly bring new therapy options to the market. Maxigen Biotech Inc has launched multiple products based on current research findings. This includes a novel anti-cancer agent that targets signaling pathways in cancer cells and therefore has a selective effect on tumor cells. Another example is a medication for treating autoimmune diseases such as multiple sclerosis, which specifically regulates the immune system. The company also has a division for the production of biological drugs. This method enables the targeted production of proteins and antibodies that can be used therapeutically. Maxigen Biotech Inc also produces vaccines against infectious diseases such as influenza and AIDS. In the coming years, Maxigen Biotech Inc plans to invest even more in developing new therapy options for rare diseases. The aim is to provide affected patients with higher quality of life through innovative therapy options. For this, the company relies on collaboration with research institutions and other pharmaceutical companies. Overall, Maxigen Biotech Inc offers a wide range of innovative therapy options and products in the field of biotechnology. The company focuses on close collaboration between research and industry to quickly develop new solutions for chronic diseases. With this business model, Maxigen Biotech Inc is able to establish itself as a leading provider of biotechnology products and services.

What is the Maxigen Biotech dividend?

Maxigen Biotech pays a dividend of 0 TWD distributed over payouts per year.

How often does Maxigen Biotech pay dividends?

The dividend cannot currently be calculated for Maxigen Biotech or the company does not pay out a dividend.

What is the Maxigen Biotech ISIN?

The ISIN of Maxigen Biotech is TW0001783009.

What is the Maxigen Biotech ticker?

The ticker of Maxigen Biotech is 1783.TW.

How much dividend does Maxigen Biotech pay?

Over the past 12 months, Maxigen Biotech paid a dividend of 0.48 TWD . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, Maxigen Biotech is expected to pay a dividend of 0.48 TWD.

What is the dividend yield of Maxigen Biotech?

The current dividend yield of Maxigen Biotech is 1.13 %.

When does Maxigen Biotech pay dividends?

Maxigen Biotech pays a quarterly dividend. This is distributed in the months of September, September, October, August.

How secure is the dividend of Maxigen Biotech?

Maxigen Biotech paid dividends every year for the past 1 years.

What is the dividend of Maxigen Biotech?

For the upcoming 12 months, dividends amounting to 0.48 TWD are expected. This corresponds to a dividend yield of 1.13 %.

In which sector is Maxigen Biotech located?

Maxigen Biotech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Maxigen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Maxigen Biotech from 8/16/2024 amounting to 0.999 TWD, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Maxigen Biotech pay the last dividend?

The last dividend was paid out on 8/16/2024.

What was the dividend of Maxigen Biotech in the year 2023?

In the year 2023, Maxigen Biotech distributed 0.664 TWD as dividends.

In which currency does Maxigen Biotech pay out the dividend?

The dividends of Maxigen Biotech are distributed in TWD.

Access the world's leading financial data and tools

Price

Price

Ticker1783.TW

ISINTW0001783009

Maxigen Biotech stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Maxigen Biotech Stock Price History

Maxigen Biotech Revenue, EBIT, Net Income TW0001783009 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Maxigen Biotech Revenue, EBIT and net profit per share

Maxigen Biotech Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Maxigen Biotech stock margins TW0001783009 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Maxigen Biotech Margin History

Maxigen Biotech Stock Sales Revenue, EBIT, Earnings per Share TW0001783009 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Maxigen Biotech Revenue, EBIT and net profit per share

Maxigen Biotech business model

Maxigen Biotech SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Maxigen Biotech Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Maxigen Biotech historical P/E ratio, EBIT multiple, and P/S ratio

Maxigen Biotech shares outstanding TW0001783009 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Maxigen Biotech stock splits

Maxigen Biotech dividend history and estimates TW0001783009 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Maxigen Biotech Dividend History

Maxigen Biotech dividend payout ratio TW0001783009 ·

Payout ratio

Ticker
1783.TW

ISIN
TW0001783009